Past News

TECHNOLOGY REDUCES DIAGNOSIS OF BRD FROM FOUR + DAYS TO ABOUT 30 MINUTES

July 15, 2020

The number one struggle Aaron Ault faces on his farm is managing bovine respiratory disease (BRD). During a bad BRD outbreak, the Indiana farmer may spend weeks pulling two to three dozen sick calves per day from his herd for treatment.

TECHNOLOGY REDUCES DIAGNOSIS OF BRD FROM FOUR + DAYS TO ABOUT 30 MINUTES

SpeechVive Raises $1.5M to Speed Company’s Growth

July 15, 2020

SpeechVive recently raised more than $1.5 million to support efforts to increase accessibility for the wearable medical device that improves the speech clarity of Parkinson’s disease patients.

SpeechVive Raises $1.5M to Speed Company’s Growth

Purdue team gets $1 million IDEAS grant to develop rapid BRD test

July 15, 2020

Purdue University researchers are developing technology to reduce diagnosis time for bovine respiratory disease, which accounts for about half of all feedlot deaths in North America and costs beef and dairy producers as much as $900 million a year.

Purdue team gets $1 million IDEAS grant to develop rapid BRD test

Purdue team gets $1 million to develop rapid sensor technology for cattle disease

July 14, 2020

Bovine respiratory disease (BRD), one of the most prevalent and costly illnesses in the beef and dairy industries, accounts for about half of all feedlot deaths in North America and costs producers as much as $900 million a year. Quickly diagnosing the illness could improve the well-being of animals and save producers significant money. Current tests don’t offer results for four or more days.

Purdue team gets $1 million to develop rapid sensor technology for cattle disease

Scientists discover antibodies to protect children from rare, polio-like disease ‘AFM’

July 14, 2020

The U.S. has been polio-free for more than 40 years, but health officials warn that a new disease is infecting children with many of the same devastating effects. Thankfully, researchers may have found a potential defense against the paralysis-causing illness, acute flaccid myelitis, or AFM.

Scientists discover antibodies to protect children from rare, polio-like disease ‘AFM’

SpeechVive receives new Level II HCPCS from the Centers for Medicare and Medicaid Services

July 14, 2020

SpeechVive Inc. announced Tuesday (July 14) that the Centers for Medicare & Medicaid Services (CMS) has issued a new Level II Healthcare Common Procedure Coding System code, which will be effective Oct.1 for the SpeechVive device.

SpeechVive receives new Level II HCPCS from the Centers for Medicare and Medicaid Services

Expert: Tech that could reduce summer road construction

July 13, 2020

U.S. roads are aging and reaching the end of their service life, resulting in the need for constant repair. States with harsher winters often see more summer road construction, but new technology being developed at Purdue University could benefit concrete infrastructure everywhere.

Expert: Tech that could reduce summer road construction

Protein Structure Modeling from Cryo-EM Map Using MAINMAST and MAINMAST-GUI Plugin

July 13, 2020

Protein structure modeling is a fundamental step for the structural interpretation of 3D electron microscopy (EM) density map. Recently, because of the significant progress of the cryo-EM technique, protein structure modeling tools are needed for EM maps determined around 4 Å resolution.

Protein Structure Modeling from Cryo-EM Map Using MAINMAST and MAINMAST-GUI Plugin

Experts: Turn off air conditioners to reduce spread of COVID-19

July 12, 2020

Air conditioners are broadly categorised into two types – ones that take in air from the outside and expel it and the ‘split units’, which recirculate the same air, Shaun Fitzgerald, a fellow at the Royal Academy of Engineering, told The Telegraph.

Experts: Turn off air conditioners to reduce spread of COVID-19

New treatment approach uses killer cells to treat deadly brain tumors

July 9, 2020

Glioblastomas are the most common malignant brain tumors in adults. Treatment options are extremely limited and usually not effective, leading to death for most patients within 12-18 months of diagnosis.

New treatment approach uses killer cells to treat deadly brain tumors